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ABSTRACT 
Felix H Peng: Characterisation of foci formed by the telomeric binding protein POT-1 in 
the developing C. elegans embryo 
(Under the direction of Shawn C. Ahmed and Paul S. Maddox) 
 
 The ends of linear chromosomes are protected by telomeres, repetitive DNA 
caps that are bound by a complex of proteins collectively known as shelterin. POT1, a 
component of shelterin, binds telomeric single stranded DNA and is important in the 
regulation of telomeres. Little is known about the regulation of telomeres in the context 
of early development. Using the early C. elegans embryo as a model, I have developed 
a system for studying telomeres in live embryos. A transgene expressing POT-
1::mCherry exhibits punctate foci at telomeres during early development. Detailed 
analysis of this transgene in a wild-type and a telomere lengthening background 
suggest that telomere length may affect POT-1 binding to telomeres. 
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Chapter I. 
INTRODUCTION 
 
Telomeres are nucleoprotein structures that function as a cap at the ends of 
linear chromosomes, and are critical for genomic stability since they protect them from 
degradation and fusion (Blackburn 1991). Telomeric DNA is composed of tandem 
TTAGGG repeats in humans (Moyzis et al. 1988), with similar G-rich repeats existing in 
other organisms, such as TTAGGC in the nematode Caenorhabditis elegans (Wicky et 
al. 1996). Telomeric DNA contains 3ʹ overhangs at its most distal part (McElligott and 
Wellinger 1997; Raices et al. 2008); these overhangs are believed to invade itself to 
form a looped structure known as the T-loop (Griffith et al. 1999). 
 Telomeres are synthesised de novo by the reverse transcriptase telomerase 
(TERT), which is composed of a catalytic subunit and an RNA template (Greider and 
Blackburn 1989; Morin 1989). Telomerase expression is repressed in normal somatic 
tissue, however, it is active in germ cells and cancer cells (Kim et al. 1994). Upwards of 
90% of tumour cells have activating mutations in TERT that compensate for gradual 
telomere shortening (Chiba et al. 2015), while the remaining proportion of tumours 
achieve this by a telomerase-independent pathway called alternative lengthening of 
telomeres (ALT) (Bryan et al. 1997).  
 Telomeres themselves are decorated by a complex of proteins collectively known 
as shelterin, which in vertebrates is composed of a core of six proteins (Figure 1A); 
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these are the double strand binding proteins TRF1 and TRF2, the adapter proteins 
RAP1, TIN2, and TPP1, and the single strand DNA binding protein POT1 (De Lange 
2005). Shelterin is critical for the maintenance of telomeres, as their removal leads to 
telomere dysfunction and chromosome fusion caused by activation of the DNA repair 
machinery (Sfeir and de Lange 2012). 
 POT1 is found in nearly all eukaryotes and has been well studied in model 
organisms ranging from budding yeast to humans. It contains two, single stranded DNA 
binding OB fold domains at its N terminal (Lei, Podell, and Cech 2004). Stoichiometric 
studies of shelterin components and co-immunoprecipitation assays suggest that there 
is a pool of POT1 that is found away from the single-stranded telomeric DNA, 
presumably associating with other shelterin components interacting with double 
stranded DNA at the T-loop (Takai et al. 2010; Loayza and De Lange 2003). Sequence 
and predicted structure homology have been used to identify four homologues of POT1 
in C. elegans. Unlike its mammalian homologues, C. elegans homologues of POT1 are 
thought to contain only one OB fold domain each; MRT-1, POT-2, and POT-3 contain 
an OB2 domain while POT-1 contains an OB1 domain (Raices et al. 2008; Meier et al. 
2009).  
C. elegans is a genetic model organism well suited for ageing studies due to its 
short generation time, ease of breeding, and the availability of genetic tools (Brenner 
1974; Jorgensen and Mango 2002). Due to its transparent cuticle and known cell 
lineage, C. elegans is also an important model organism in studying cell biological 
processes and development (Sulston et al. 1983). Prior studies have established that C. 
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elegans telomeres are roughly 2 kilobases (kb) in length, and that like human telomeres, 
C. elegans telomeres form T-loops (Raices et al. 2008). For these reasons, we use this 
organism as a model for study of telomeres. 
Prior work in our lab has shown that a POT-1::mCherry transgene localises to 
telomeric foci in vivo, and that both POT-1 and POT-2 repress telomerase activity 
(Shtessel et al. 2013). Observations from this and another independent study suggest 
that POT-1 and POT-2 also have a function in repressing ALT, and pot-2 mutants were 
shown to have telomeres of roughly 12 kb in length after passaging for ~10 generations 
(Cheng et al. 2012; Shtessel et al. 2013). Our previous observations suggested that 
early embryos did not express POT-1 in early embryos, leading us to initially ask when 
telomeric foci first form during embryonic development and how they compare with 
telomeres in the adult germline or in larval stages of development. 
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Figure 1. Schematic of the telomere and the associated shelterin complex. 
Telomeres form a looped structure referred to as a T-loop, which is bound by a complex 
of six proteins collectively known as shelterin, of which POT1 binds to single stranded 
DNA in a structure known as the D-loop (mammalian components and names shown in 
panel A). C. elegans homologues of human POT1. POT-1 and POT-2 have been shown 
to inhibit both telomerase-dependent and ALT-dependent telomere elongation (Cheng et 
al. 2012; Shtessel et al. 2013; B). 
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Chapter II. 
MATERIALS AND METHODS 
 
 All strains were grown at 20°C on nematode growth medium seeded with the 
OP50 strain of Escherichia coli. The following strains were used during the course of 
this study: pot-1::mCherry (yp4), pot-1::mCherry; pot-2, and dpy-7; unc-4. Strains used 
from the Million Mutation Project (Thompson et al. 2013) are VC20684, VC40603, 
VC40919.  
 The DNA sequence of the pot-1 3ʹ UTR was synthesised as a gBlock (Integrated 
DNA Technologies) and directly cloned into L4440 using T4 ligase (New England 
Biolabs). DNA was extracted after bacterial transformation using EZNA Plasmid DNA 
Mini Kit (Omega Bio-Tek). After proper DNA insertion was confirmed through 
sequencing, the plasmid was transformed into HCT115 bacteria.  
 Live cell imaging of C. elegans embryos was performed as follows. Embryos 
were dissected from 7~10 gravid worms in M9 media. The embryos were then 
transferred to a 2% agar pad, where they were arranged in close proximity to each other 
with an eyelash tool. These embryos were then covered with a 1.5 thickness cover slip 
and sealed with Valap (Vaseline, Lanolin, Parrafin), then imaged using a DeltaVision 
Elite (GE Healthcare) running Softworx 5.5 (GE Healthcare). Images were acquired 
using a CoolSnap HQ2 CCD camera (Photometrics). 
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 Unless otherwise noted, embryos were imaged using 60x oil immersion objective 
with a numerical aperture of 1.42. Z-stack images were acquired by exposure to light for 
.300 s per slice with a .500 μm interval between slices. Light at 32% transmission from 
the source was used to excite samples. To maximise POT-1::mCherry signal, images 
were acquired using 2x2 pixel binning. 
 Images were processed and analysed using Fiji (Schindelin et al. 2012). Data 
were input and calculated in Microsoft Excel for Mac 2011 (Microsoft Corporation). 
Statistical analysis and data output was performed in GraphPad Prism 6 for Windows 
(GraphPad Software, Inc.). Detailed protocols for image analysis is listed in the 
Appendix. 
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Chapter III.  
RESULTS 
 
 Establishing a system for studying telomeric foci in live embryos. In order 
to understand the behaviour of telomeric foci of POT-1::mCherry, I established a system 
to image embryos live. Prior work performed to characterise the pot-1::mCherry 
transgene was performed in intact adult worms (Shtessel et al. 2013). However, 
embryos may be obscured by the highly autofluorescent gut of the animal. I thus 
decided to dissect out embryos for imaging. As described previously, POT-1::mCherry 
form bright, punctate foci in the nucleus of embryos (Shtessel et al. 2013). I attempted 
to image embryos using time-lapse microscopy, but found that under the conditions 
used, the POT-1::mCherry signal photobleached after two cell divisions, or around 15—
20 minutes  (Figure 2). Using this method, I observe that mCherry signal varies as cells 
cycle, with signal intensifying as chromosomes condense during mitosis. However, the 
bleaching of the signal makes it very difficult to determine the stage at which POT-
1::mCherry foci persist through interphase. 
I therefore elected to dissect out embryos from a number of adults and image a 
large population of them at a single time point. While this method prevents us from 
tracking an individual embryo over time, I am able to image embryos at varying stages 
of development. This method allows us to effectively examine the behaviour of POT-
1::mCherry at different stages of development, and also maintains the variation in POT-
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1::mCherry expression during early stages of embryogenesis (representative image 
shown in Figure 3).  
 POT-1::mCherry foci are visible in mitosis, but not interphase in the first 
cell divisions. Using this system to visualise pot-1::mCherry embryos, I find that POT-
1::mCherry form discrete, punctate foci in the germline and in embryos, as previously 
reported (Shtessel et al. 2013). I observe that in earlier stages of embryogenesis (1, 2, 
and 4 cell stages) foci are visible in interphase at lower proportions than in later stages. 
However, our imaging reveals that POT-1::mCherry foci are visible during mitotic stages 
in these cell divisions, and that the proportion of cells with visible foci during interphase 
increases as embryogenesis progresses, with nearly all interphase nuclei exhibiting foci 
by the 8-cell stage (Figure 4A). Quantification of the number of foci in each nucleus 
reveals that while the number of foci per nucleus is highly variable, they appear to 
increase as development progresses (Figure 4B).   
 The number of telomeric foci differs between a telomere lengthening strain 
and wild-type worms. While I observe focus formation in embryos from a pot-
1::mCherry strain, the foci are often accompanied by a nucleoplasmic haze (Figure 5A). 
In contrast, embryos of a pot-1::mCherry; pot-2 background that had been passaged for 
a very long number of generations (≥F100) notably did not exhibit this diffuse 
expression pattern, but rather the telomeric foci were brighter and the nucleoplasmic 
haze was diminished (Figure 5B). I quantified the number of foci in embryos of both 
genotypes (Figure 5C), and found that pot-1::mCherry; pot-2 embryos had a significantly 
higher number of foci than the otherwise wild-type (WT) strain. 
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 Development of a quantitative measure of POT-1::mCherry focus 
localisation using nuclear contrast. While I clearly observed that embyros from a pot-
1::mCherry; pot-2 background had more foci and did not exhibit nucleoplasmic haze 
(Figure 4), I wished to be able to quantitate this otherwise qualitative observation. To 
that end, I established a quantitative assay based on contrast to quantify our 
observations. Here, I define contrast as the maximum grey value divided by the mean of 
the grey values within a region of interest (ROI). I reasoned that pot-1::mCherry 
embryos, with their nucleoplasmic haze, would have a lower measure of contrast than 
nuclei from pot-1::mCherry; pot-2 embryos, since the maximum grey value would be 
divided by a much smaller number in the latter genotype (Figure 6A). Indeed, the 
contrast measured using this method is higher in pot-1::mCherry; pot-2 embryos 
compared to those from a pot-1::mCherry alone background (Figure 6B). 
 Knockdown of endogenous POT-1 and POT-2 does not significantly alter 
contrast measurements compared to pot-1::mCherry WT worms. Since pot-
1::mCherry strain used in these experiments contained endogenous POT-1 in addition 
to the mCherry tagged POT-1, I asked whether or not the depletion of endogenous 
POT-1 would affect the expression of POT-1::mCherry as seen in Figure 4. I reasoned 
that the pool of endogenous POT-1 could be competing with POT-1::mCherry for 
binding sites at telomeres, hypothesising that knockdown of POT-1 would lead to 
improved binding of POT-1::mCherry, thus increasing measured contrast. Given that 
pot-2 mutations led to increased telomere length, I also asked if depletion of pot-2 could 
increase contrast measurements by providing longer telomere binding sites for POT-
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1::mCherry. I therefore hypothesised that POT-1::mCherry contrast measurements 
could be affected by depletion of pot-2 mRNA.   
 C. elegans can respond bacteria expressing dsRNA to generate knockdown 
(Timmons and Fire 1998) and a library has been generated in C. elegans against nearly 
every known gene in its genome (Kamath et al. 2003), including pot-1. However, the 
dsRNA found here targets the entire coding region of the pot-1 mRNA, making it 
inappropriate for use in our POT-1::mCherry strain. I thus generated a dsRNA that 
targets only endogenous pot-1 by cloning the 3ʹ UTR of the gene into the L4440 vector 
backbone used in the Ahringer library.  
 pot-1::mCherry worms were picked at larval stage L4 and fed bacteria expressing 
two independent constructs expressing dsRNA against endogenous pot-1 for 48h. I fed 
pot-1::mCherry worms bacteria expressing dsRNA against pot-2 mRNA for the same 
amount of time.  Embryos were dissected and imaged as previously described. I found 
that feeding dsRNA against endogenous pot-1 and pot-2 does not appear to alter POT-
1::mCherry focus formation or contrast in a significant manner (Figure 7). 
 Crossing pot-1::mCherry with pot-1::mCherry; pot-2 worms reveals that 
POT-1::mCherry foci are visible in pronuclei from pot-2 parents. I asked if the 
increased contrast observed in nuclei from pot-1::mCherry; pot-2 was parent-specific. 
To that end, I set up a pair of reciprocal crosses between pot-1::mCherry and pot-
1::mCherry; pot-2 worms. pot-1::mCherry hermaphrodites were mated with pot-
1::mCherry; pot-2 males, and vice versa for 24h. Embryos were dissected and time-
lapse movies were made (Figure 8). As can be seen in the montages in Figure 8, 
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pronuclei from a pot-1::mCherry; pot-2 background are visible before the first cell 
division, regardless of the parent. These results suggest that the increase in contrast 
that is seen in the pot-1::mCherry; pot-2 embryos is a result of the long telomeres that 
are present in the pot-2 mutant background, or perhaps a consequence of a process 
associated with long telomeres after growth for many generations in the absence of pot-
2. 
 Worms with lengthened telomeres of varying genetic backgrounds yield an 
increase in foci compared to WT backgrounds. To further understand whether or not 
the contrast observed is due to telomeric length or by some other means, we turned to 
strains generated by the Million Mutation Project (Thompson et al. 2013), which 
generated a library of 2 007 mutagenised strains that contained mutant alleles for each 
of the worm’s ~20 000 genes. I generated marked pot-1::mCherry worms to cross into 
three Million Mutation Project strains, all of which were shown by deep sequencing to 
have significantly lengthened telomeres (Thompson et al. 2013).  
 After crossing pot-1::mCherry to Million Mutation Project worms, I selected twelve 
F2 worms from each cross to propagate. After passaging each line for a few 
generations to allow for telomere lengthening, I dissected and imaged embryos as 
previously described. I find that the number of foci in early generations after outcrosses 
with the Million Mutation Project strains was often higher than for WT, but not as high as 
in embryos derived form very late-generation pot-1::mCherry; pot-2 strains (Figure 9).  
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Figure 2. Montage of time-lapse images of a pot-1::mCherry embryo showing 
nearly complete photobleaching after two cell divisions. In this representative, 
maximum intensity montage of a pot-1::mCherry embryo, I see that embryos bleach 
after approximately two cell divisions. I observe that mCherry signal varies as cells 
cycle, with signal intensifying as chromosomes condense during mitosis. However, the 
photobleaching makes it very difficult to accurately determine the stage at which POT-
1::mCherry foci persist through interphase. Scale bar represents 20 μm. 
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Figure 3. Embryos are imaged at single timepoints to determine the stage at 
which foci persist through interphase. To overcome difficulties in determining the 
embryonic stage at which POT-1::mCherry foci persist through interphase due to 
photobleaching, I dissected out embryos from 7–10 worms and imaged them at a single 
timepoint, thus capturing a large population of embryos at various stages of 
development. The dashed gold line indicates a 2-cell embryo during interphase not 
expressing POT-1::mCherry. The red arrowhead indicates the POT-1::mCherry signal in 
an embryo undergoing its first cell division. Scale bar represents 20 μm. 
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Figure 4. Quantification of embryos with persistent mCherry foci in a wild-type 
background. Quantification of the proportion of pot-1::mCherry embryos with foci 
during interphase (blue bars) compared to mitosis (grey) showing that while pot-
1::mCherry embryos consistently exhibit foci during mitosis, embryos do not show 
persistent foci formation in interphase until the 8 cell stage (n = 335 nuclei; A). The 
number of foci per nucleus is highly variable, but we observe an upward trend as 
development progresses (B). (n = 515 nuclei analysed. Error bars in B represent SD). 
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Figure 5. Localisation of POT-1::mCherry differs in different telomeric 
backgrounds, and the number of foci is almost doubled in a telomere lengthening 
background. POT-1::mCherry in an otherwise WT background shows a nucleoplasmic 
haze (A). POT-1::mCherry in the telomere lengthening background pot-2 localise almost 
exclusively to telomeric foci (B). Histogram depicting the distribution of foci/nucleus (n = 
592 pot-1::mCherry, 295 pot-1::mCherry; pot-2 nuclei) Scale bars represent 20 μm. 
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Figure 6. Development of a quantitative measure of POT-1::mCherry localisation 
in nuclei. Z stacks are flattened by maximum intensity projection, and ROIs are drawn 
around nuclei (yellow circles in panel A). Fiji is used to calculate the maximum grey 
value and the mean grey value within the ROI, and contrast is calculated by dividing the 
former by the latter. I find that pot-1::mCherry; pot-2 worms have significantly higher 
contrast measurements than their WT counterparts, with an increase in mean contrast 
of 27.1% (n = 269 WT, 431 pot-1::mCherry; pot-2 nuclei, B).  
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Figure 7. Knockdown of endogenous pot-1 and pot-2 does not appear to 
noticeably affect contrast or focus formation. Representative images of embryos fed 
dsRNA against endogenous pot-1 (A) and pot-2 (C). Contrast measurements for two 
independent plasmids against endogenous pot-1 yield no significant increase in contrast 
after 48h feeding (n = 222 nuclei endo pot-1 construct 3, 247 nuclei construct 3 L4440 
(ctrl); n = 247 nuclei endo. pot-1 construct 5, 318 nuclei construct 5 L4440 (ctrl); B). 48h 
RNAi feeding against pot-2 does not result in a significant increase in nuclear contrast 
(n = 185 nuclei L4440, 123 nuclei pot-2 RNAi; D). Scale bars represent 20 μm. Error 
bars represent SD. 
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Figure 8. POT-1::mCherry foci are visible in pronuclei derived from ALT-
dependent telomere lengthening mutants. pot-1::mCherry; pot-2 males were 
crossed with pot-1::mCherry hermaphrodites (top row, DIC reference image on right), as 
was a reciprocal cross (bottom row, DIC reference image on right). Even before 
pronuclear fusion, POT-1::mCherry foci are visible in the pronucleus derived from the 
pot-2 background with elongated telomeres. Scale bars represent 20 μm. 
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Figure 9. Million Mutation Project strains with lengthened telomeres exhibit an 
increase in the number of foci counted per nucleus. Representative maximum 
intensity projection of pot-1::mCherry crossed to Million Mutation Project strains with 
lengthened telomeres (A). Quantitation of foci of these worms reveal an increase in the 
number of foci per nucleus in long telomere strains versus pot-1::mCherry alone, though 
the number of foci is not as high as seen in the ALT mutant pot-2 background (n = 592 
pot-1::mCherry, 295 pot-1::mCherry; pot-2, 288 pot-1::mCherry; VC20684, 216 pot-
1::mCherry; VC40603, 216 pot-1::mCherry; VC40919 nuclei B). Scale bars represent 20 
μm.  
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Chapter IV.  
DISCUSSION 
 
 Here I have performed detailed analysis of the telomere binding protein POT-1 
during early development. By employing live-cell imaging, we have determined that 
POT-1::mCherry foci appear persistently through the cell cycle at around the 8-cell 
stage, with POT-1::mCherry signal appearing only during mitosis in stages before then. I 
have also determined that the number of foci per nucleus increases as development 
progresses (Figure 4). Using nuclear contrast as a quantitative measure of POT-1 
binding to foci, I observe that telomeric localisation of POT-1::mCherry increases in 
backgrounds of increased telomere length. Specifically, I examined POT-1::mCherry 
localisation in strains that either contained a known ALT phenotype (pot-2) or with 
several mutations that can cause long telomeres (Million Mutation Project).  
 In this study, I compare the expression of POT-1::mCherry in a WT and pot-2 
background in which telomeres have had many generations to increase in length. I 
observed that POT-1::mCherry expresses in a diffuse nucleoplasmic pattern in WT 
worms (Figure 5A), but that this diffuse expression is absent in a background where 
telomeres have been elongated via ALT (Figure 5B). Our data therefore suggest that in 
the telomere lengthening background, POT-1::mCherry localises to a greater number of 
more intense foci. 
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 I asked if the abundance of endogenous, untagged POT-1 protein could be 
affecting the localisation of our tagged transgene. By using RNAi against endogenous 
POT-1, I could not measure a significant difference in contrast (Figure 7). Similarly, 
when asking if an acute (48h) knockdown of pot-2 could trigger ALT-dependent 
telomere lengthening, I was unable to measure a significant difference in contrast. In 
fact, mean contrast appears to have decreased in pot-2 knockdown worms compared to 
a feeding control. While my results suggest that there is not a significant difference in 
contrast between the POT-1::mCherry signal fed a control vector and the knockdowns 
we generated, we cannot rule out that the RNAi may not have been effective. Since no 
antibody against POT-1 or POT-2 has been reported to our knowledge, we are unable 
to probe the effectiveness of RNAi knockdown by western blotting. Validation of 
knockdowns of both genes tested will be important controls to conduct in future 
experiments. Additional experiments using genetic nulls of both endogenous pot-1 and 
pot-2 may also be effective in helping us understand these questions. 
 I was unable to answer whether or not length could be a factor affecting POT-
1::mCherry association with telomeres through RNAi. However, genetic evidence 
suggests that telomere length may indeed affect POT-1::mCherry binding to telomeres. 
Importantly, I generated males of both pot-1::mCherry and pot-1::mCherry; pot-2. These 
males were crossed to hermaphrodites of the opposing genotype, and time-lapse 
imaging was used to track the pronuclei of both parents as fertilisation occurred. Our 
resulting movies revealed that only the pronucleus derived from the parent with a pot-2 
mutant background had any visible foci, and that these foci were visible throughout the 
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process of pronuclear fusion (Figure 9). Given that the pot-2 mutants were passaged for 
many (≥100) generations and presumably have very long telomeres, these data suggest 
either that telomere length could be a significant factor in determining the amount of 
POT-1 binding, or that the absence of POT-2 in pronuclei lead to the presence of POT-1 
foci in 1 cell stage nuclei prior to mitosis. 
 The worm strains used in this study contain a pot-1::mCherry transgene 
generated by the mosSCI single copy insertion protocol (Frokjaer-Jensen et al. 2014) to 
allow for the targeted insertion of a transgene at a defined location in the genome. While 
the pot-1::mCherry strain used in this study is a valuable tool for studying telomeres in 
vivo, there are shortcomings. Notably, pot-1::mCherry is not expressed under the 
endogenous pot-1 promoter, instead being expressed under the germline specific daz-1 
promoter (Maruyama et al. 2005). The POT-1::mCherry signal I observed could be a 
result of POT-1 overexpression, as endogenous pot-1 was not ablated. To address this, 
it is possible that Cas-9 mediated genome editing may be employed to tag endogenous 
pot-1 with either GFP or mNeonGreen (Cong et al. 2013; Mali et al. 2013; Dickinson et 
al. 2013; Dickinson et al. 2015). However, these efforts have not been successful to 
date (Table 1 summarises the primers used in these efforts). 
Our data suggest a model by which long telomeres correlate with greater binding 
of POT-1::mCherry, accounting for the increased number of foci and increased 
intensities of foci observed in the pot-2 mutant background (Figure 10). We can 
speculate that prolonged loss of pot-2 or an epigenetic state that accompanies long 
telomeres in combination with pot-2 deficiency could also lead to these phenotypes. 
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POT-1 binds single stranded DNA at telomeres specifically (Lei, Podell, and Cech 
2004), but it is thought that a fraction of POT-1 is also found at other parts of the 
telomere (De Lange 2005; Palm and de Lange 2008; Takai et al. 2010), most likely in 
association with other shelterin components. In the pot-2 deletion background, 
telomeres have elongated significantly after many generations of passaging, thus 
providing a longer binding substrate for shelterin components, and especially POT-1, to 
associate with. This could imply increased single stranded DNA at elongated telomeres. 
Given that POT-1 foci in early embryos can be observed in parental pronuclei derived 
from pot-1::mCherry; pot-2 gametes, my observations suggest that telomere length, 
possibly in combination with loss of POT-2, could contribute to visibility of POT-1 foci in 
early embryos. One could speculate that the presence of these foci could reflect 
increased telomerase activity or increased activity of the telomerase independent 
telomere elongation pathway ALT. Future work may address these possibilities.  
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Figure 10. Model for telomeric focus formation in a wild-type versus telomere-
lengthening background. WT telomeres are roughly 2 kb in length (Raices et al. 
2008), yielding baseline contrast measurements. Knockdown of pot-2 does not appear 
to appreciably alter contrast, but a genetic mutant of the gene appears that has been 
passaged for many generations does. This is suggestive of a model in which the loss of 
POT-2, the lengthening of telomeres, or both, may perturb the localisation of POT-
1::mCherry to telomeres. 
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Table 1. List of primers used in attempts to endogenously tag POT-1 using 
CRISPR. List of primers used in attempts to endogenously tag POT-1 using the SEC 
protocol developed by Dickinson and colleagues (Dickinson et al. 2015). All primers are 
listed in 5ʹ to 3ʹ direction. 
 
Name Sequence 
pot1-5-fwd ACGTTGTAAAACGACGGCCAGTCGCCGGCATGTCGGTTCTGTCAAG
GTTAGCC 
pot1-5-rev CATCGATGCTCCTGAGGCTCCCGATGCTCCAATATTAATATTGTAGAA
AACAACTTCGG 
pot1-3-fwd CGTGATTACAAGGATGACGATGACAAGAGAGATATTCATCTCTCCGA
AGTTGTTTTCTAC 
pot1-3-rev GGAAACAGCTATGACCATGTTATCGATTTCAGAAATCTCTGGGCCAC
CAACAG 
p1-SDMF GAAGTTGTTTTCTACAATATTAATATTGGAGCATC 
p1-SDMR GGAGAGATGAACAATTGACTTCAATTCAAGTGAAC 
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APPENDIX: Image Analysis Protocols 
 Part I. Measurement of contrast is performed according to the following protocol: 
 1. Image is opened in Fiji. If image was acquired as a panel image, a Bio-
Formats Series Options window will open, prompting the user to select the panels of 
interest. 
 2. Brightness and contrast are reset, either manually (in single panels using 
Brightness and Contrast tool) or by “Reset Min Max” macro (batch processing, source 
code can be found at the end of this section). 
 3. For contrast measurements, panels are Z projected manually (individual 
panels, or panels requiring a projection of a subset of total slices) or via “Batch MIP” 
macro (source code can be found at the end of this selection). 
 4. ROIs are selected using freehand selection tool with the aide of a Wacom 
Intuos tablet and added to Fiji’s integrated ROI manager. 
 5. For background noise correction, 10 circular ROIs 7 pixels in diameter are 
selected in the background (i.e. non-cytoplasmic, non-embryonic signals), and included 
as the final ROIs in the ROI manager. 
 6. ROIs in ROI manager are measured, with the following parameters being 
recorded (measurements can be set using “Analyze > Set Measurements…” command 
in the Fiji Menu Bar): 
 Area – Area of ROI 
 Mean – Average grey value of ROI 
 StdDev – Standard deviation of grey values of ROI 
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 Min – Minimum grey value in ROI 
 Max – Maximum grey value in ROI 
 IntDen – Integrated density, this is the product of the area and mean grey value. 
It is important to note that this value should not be used in our 
calculations. Inclusion of this value is necessary to obtain measurements 
of RawIntDen. 
 RawIntDen – Raw integrated density, also known as Integrated Intensity, is the 
sum of the all pixel values in the ROI being measured. It is not to be confused 
with the Integrated Density measurement used in Fiji. We use this 
measurement in our calculations. 
 7. Measured values in Results window are copied to an Excel worksheet. 
 8. Average background is calculated by averaging the mean values of the 
background ROIs selected in step 5. 
 9. Corrected Mean and Max are calculated by subtracting value calculated in 
step 8 from measured mean and max values. 
 10. Corrected contrast is calculated by dividing corrected maximum value by 
corrected mean value. 
 Part II. Measurement of Integrated Intensity is performed identically to steps 1–8 
in Part I. The calculated average background is multiplied by the area of the ROI. This 
value is then subtracted from the Integrated Intensity value obtained in step 6 of Part I.  
 Part III. Focus counts are performed manually. The image panel is opened as in 
steps 1 and 2 in Part I. Nuclear foci are counted in each slice, and are marked using the 
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Multi-point tool in Fiji. The number of points are counted, and the resulting value input 
into Excel. 
 Part IV. Source code for “Reset Min Max” 
for (id = 1; id <= nImages(); id++) 
{ 
 selectImage(id); 
 resetMinAndMax(); 
} 
 
 Part V. Source code for “Batch MIP” 
for (id = 1; id <= nImages(); id++) 
{ 
 selectImage(id); 
 resetMinAndMax(); 
 run("Z Project...", "projection=[Max Intensity]"); 
} 
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